This is a request to continue research on the role of central NE systems projecting from the nucleus locus coeruleus (LC) in behavior and the effects of drugs. Prior studies suggested that the LC might be part of the neural substrate for anxiety/fear, for therapeutic actions of anxiolytics, and for some drug withdrawal syndromes. The effects of the alpha-2 adrenoceptor agonist clonidine on anxiety and morphine withdrawal in humans and the anxiety-producing effects of the alpha-2 antagonist yohimbine are consistent with this hypothesis. Proposed experiments will determine (a) whether acute and chronic lesions of the LC will block the behavioral and physiological responses to conditioned """"""""fear"""""""" or (b) to morphine withdrawal in animals, whether activation produces opposite effects in a receptor-specific fashion, and whether fear-inducing stimuli increase LC function measured biochemically and electrophysiologically. (c) Clinical studies will test the therapeutic and NE-system altering effects of three dissimilar compounds, clonidine, alprazolam, and imipramine. Plasma MHPG (the major norepinephrine metabolite which parallels brain concentrations in monkeys), autonomic signs, and anxiety or panic in patients with agoraphobia and panic attacks will be measured during treatment. Patients will be """"""""challenged"""""""" with yohimbine and caffeine, two compounds reported to elicit anxiety, before and after treatment. Emotional and noradrenergic system responses will be compared with healthy control subjects. These studies, together with previous data, may confirm the involvement of central noradrenergic activity and the LC in anxiety and morphine withdrawal, and begin to determine the aspects of neural plasticity or pathophysiology that may underlie anxiety disorders and chronic drug addiction, two of the most common mental disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Award (K05)
Project #
5K05MH000643-09
Application #
3075820
Study Section
Research Scientist Development Review Committee (MHK)
Project Start
1985-09-23
Project End
1990-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
9
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Redmond Jr, D Eugene; Evans, Lawrence (2012) Determination of fetal age by ultrasonography in St. Kitts green monkeys. Am J Primatol 74:433-41
Leranth, Csaba; Shanabrough, Marya; Redmond Jr, D Eugene (2002) Gonadal hormones are responsible for maintaining the integrity of spine synapses in the CA1 hippocampal subfield of female nonhuman primates. J Comp Neurol 447:34-42
Collier, Timothy J; Sortwell, Caryl E; Elsworth, John D et al. (2002) Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. J Comp Neurol 442:320-30
Kozlowski, D A; Bremer, E; Redmond Jr, D E et al. (2001) Quantitative analysis of transgene protein, mRNA, and vector DNA following injection of an adenoviral vector harboring glial cell line-derived neurotrophic factor into the primate caudate nucleus. Mol Ther 3:256-61
Elsworth, J D; Taylor, J R; Sladek Jr, J R et al. (2000) Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience 95:399-408
Jentsch, J D; Taylor, J R; Elsworth, J D et al. (1999) Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits. Neuroscience 90:823-32
Taylor, J R; Elsworth, J D; Lawrence, M S et al. (1999) Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol 158:214-20
Lawrence, M S; Foellmer, H G; Elsworth, J D et al. (1999) Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus. Gene Ther 6:1368-79
Jentsch, J D; Taylor, J R; Redmond Jr, D E et al. (1999) Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology (Berl) 142:78-84
Sladek Jr, J R; Collier, T J; Elsworth, J D et al. (1998) Intrastriatal grafts from multiple donors do not result in a proportional increase in survival of dopamine neurons in nonhuman primates. Cell Transplant 7:87-96

Showing the most recent 10 out of 35 publications